77 related articles for article (PubMed ID: 25224937)
1. Do plasma concentrations of apelin predict prognosis in patients with advanced heart failure?
Dalzell JR; Jackson CE; Chong KS; McDonagh TA; Gardner RS
Biomark Med; 2014; 8(6):807-13. PubMed ID: 25224937
[TBL] [Abstract][Full Text] [Related]
2. Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction.
Chandrasekaran B; Kalra PR; Donovan J; Hooper J; Clague JR; McDonagh TA
J Card Fail; 2010 Jul; 16(7):556-61. PubMed ID: 20610231
[TBL] [Abstract][Full Text] [Related]
3. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
[TBL] [Abstract][Full Text] [Related]
4. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure.
Velibey Y; Golcuk Y; Golcuk B; Oray D; Atilla OD; Colak A; Kurtulmus Y; Erbay AR; Yilmaz A; Eren M
Am J Emerg Med; 2013 Dec; 31(12):1634-7. PubMed ID: 24055249
[TBL] [Abstract][Full Text] [Related]
5. Plasma apelin concentration is depressed following acute myocardial infarction in man.
Weir RA; Chong KS; Dalzell JR; Petrie CJ; Murphy CA; Steedman T; Mark PB; McDonagh TA; Dargie HJ; McMurray JJ
Eur J Heart Fail; 2009 Jun; 11(6):551-8. PubMed ID: 19351633
[TBL] [Abstract][Full Text] [Related]
6. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure.
Mehra MR; Uber PA; Lavie CJ; Milani RV; Park MH; Ventura HO
J Heart Lung Transplant; 2009 Sep; 28(9):876-80. PubMed ID: 19716038
[TBL] [Abstract][Full Text] [Related]
8. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy.
Miettinen KH; Magga J; Vuolteenaho O; Vanninen EJ; Punnonen KR; Ylitalo K; Tuomainen P; Peuhkurinen KJ
Regul Pept; 2007 May; 140(3):178-84. PubMed ID: 17223209
[TBL] [Abstract][Full Text] [Related]
9. Apelin: a new plasma marker of cardiopulmonary disease.
Goetze JP; Rehfeld JF; Carlsen J; Videbaek R; Andersen CB; Boesgaard S; Friis-Hansen L
Regul Pept; 2006 Jan; 133(1-3):134-8. PubMed ID: 16263185
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Serum Apelin Level in Children with Heart Failure Secondary to Congenital Heart Disease.
El Amrousy D; El-Mahdy H
Pediatr Cardiol; 2018 Aug; 39(6):1188-1193. PubMed ID: 29632960
[TBL] [Abstract][Full Text] [Related]
11. Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
Berger R; Shankar A; Fruhwald F; Fahrleitner-Pammer A; Freemantle N; Tavazzi L; Cleland JG; Pacher R
Eur Heart J; 2009 Sep; 30(17):2109-16. PubMed ID: 19493864
[TBL] [Abstract][Full Text] [Related]
12. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?
Gardner RS; Henderson G; McDonagh TA
J Heart Lung Transplant; 2005 Mar; 24(3):303-9. PubMed ID: 15737757
[TBL] [Abstract][Full Text] [Related]
13. Transcardiac gradients of circulating apelin: extraction by normal hearts vs. release by hearts failing due to pressure overload.
Helske S; Kovanen PT; Lommi J; Turto H; Kupari M
J Appl Physiol (1985); 2010 Dec; 109(6):1744-8. PubMed ID: 20864562
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Hartmann F; Packer M; Coats AJ; Fowler MB; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Anker SD; Amann-Zalan I; Hoersch S; Katus HA
Circulation; 2004 Sep; 110(13):1780-6. PubMed ID: 15381643
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction.
Sans-Roselló J; Casals G; Rossello X; González de la Presa B; Vila M; Duran-Cambra A; Morales-Ruiz M; Ferrero-Gregori A; Jiménez W; Sionis A
Clin Biochem; 2017 Apr; 50(6):279-284. PubMed ID: 27889567
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
17. Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
Richter B; Koller L; Hohensinner PJ; Rychli K; Zorn G; Goliasch G; Berger R; Mörtl D; Maurer G; Huber K; Pacher R; Wojta J; Hülsmann M; Niessner A
Thromb Haemost; 2012 Dec; 108(6):1220-7. PubMed ID: 23014777
[TBL] [Abstract][Full Text] [Related]
18. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
20. Apelin and cardiac function in hemodialyzed patients: possible relations?
Małyszko J; Małyszko JS; Koźminski P; Myśliwiec M
Am J Nephrol; 2006; 26(2):121-6. PubMed ID: 16549903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
